Cargando…
Development of a practical synthesis of etravirine via a microwave-promoted amination
BACKGROUND: Etravirine (ETV) was approved as the second generation drug for use in individuals infected with HIV-1 in 2008 by the U.S. FDA with its unique antiviral activity, high specificity, and low toxicity. However, there are some shortcomings of the existing synthetic routes, such as the long r...
Autores principales: | Feng, Da, Wei, Fenju, Wang, Zhao, Kang, Dongwei, Zhan, Peng, Liu, Xinyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768033/ https://www.ncbi.nlm.nih.gov/pubmed/30569261 http://dx.doi.org/10.1186/s13065-018-0504-4 |
Ejemplares similares
-
Profile of etravirine for the treatment of HIV infection
por: Tseng, Alice, et al.
Publicado: (2010) -
Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs
por: Kang, Dongwei, et al.
Publicado: (2020) -
Etravirine Pharmacokinetics in HIV-Infected Pregnant Women
por: Mulligan, Nikki, et al.
Publicado: (2016) -
The development of an effective synthetic route of lesinurad (RDEA594)
por: Meng, Qing, et al.
Publicado: (2017) -
The role of etravirine in the management of treatment-experienced pediatric patients with HIV
por: Osterholzer, Danielle
Publicado: (2013)